17 β-estradiol increases calcium content in fetal mouse parietal bones cultured in serum-free medium only at physiological concentrations

Bone

Volumn 19, Issue 3, 1996, Pages 213-221

  Sato, Kanji ^a   Nohtomi, K ^b   Shizume, K ^b   Demura, H ^a   Kanatani, H ^c   Kiyoki, M ^c   Ohashi, Y ^d   Ejiri, S ^e   Ozawa, H ^e  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Res Inst for Growth Sci in Japan   (Japan)

^c TEIJIN LTD   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

Author keywords

17 estradiol; Bone formation; Calcification; Calcium; Estrogens; Phosphate

Indexed keywords

ANTIESTROGEN; CALCIUM; ESTRADIOL; FULVESTRANT; INSULIN; PHOSPHATE; TRANSFERRIN;

ANIMAL TISSUE; ARTICLE; BONE MATRIX; BONE MINERALIZATION; CALCINOSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CALVARIA; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; ELECTRON MICROSCOPY; FEMALE; FETUS; MALE; MICROSCOPY; MOUSE; NONHUMAN; ORGAN CULTURE; SKULL;

EID: 0030248245     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(96)00197-4     Document Type: Article

References (44)

1. 3. Endocrinology 133:553-562; 1993.
2. 2. Brandi, M. L., Crescioli, C., Tanini, A., Frediani, U., Agnusdei, D., and Gennari, C. Bone endothelial cells as estrogen targets. Calcif Tissue Int 53:312-317; 1993.
3. 3. Butcher, R. L., Collins, E. E., and Fugo, N. W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrus cycle of the rat. Endocrinology 94:1704-1708; 1974.
4. 4. Canalis E. Regulation of bone remodelling. Favus, M. J., ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, 2nd ed. New York: Raven; 1993; 33-37.
5. 5. Caputo, C. B., Meadows, D., and Raisz, G. L. Failure of estrogens and androgens to inhibit bone resorption in organ culture. Endocrinology 98:1065-1068; 1976.
6. 6. Castagmetta, L. A., Micelli, M. D., Sorci, C. M., Pfeffer, U., Faruggio, R., Oliveri, G., Calabro, M., and Carruba, G. Growth of LNCap human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 136:2309-2319; 1995.
7. 7. Chow, J. M. W., Lean, J. M., and Chambers, T. J. 17β-Estradiol stimulates cancellous bone formation in female rats. Endocrinology 130:3025-3032; 1992.
8. 8. Chow, J., Tobias, J. H., Colston, K. W., and Chambers, T. J. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89:74-78; 1992.
9. 9. Colvard, D. S., Eriksen, E. F., Keeling, P. E., Wilson, E. M., Lubahn, D. B., French, F. S., Riggs, B. L., and Spelsberg, T. C. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 86:854-857; 1989.
10. 10. Ericksen, E. F., Colvard, D. S., Berg, N. J., Graham, M. L., Mann, K. G., Spelberg, T. C., and Riggs, B. L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86; 1988.
11. 11. Ernst, M., Schmidt, C., and Froesch, E. R. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA 85:2307-2310; 1988.
12. 12. Ernst, M., Heath, J. K., and Rodan, G. A. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825-833; 1989.
13. 3, and interleukin 1 in fetal mouse forearm bones. Calcif Tissue Int 47:178-182; 1990.
14. 14. Fukayama, S. and Tashjian, A. H., Jr. Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 124:397-401; 1989.
15. 15. Girasole, G., Jilka, R. L., Passeri, G., Boder, G., Williams, D. C., and Manolagas, S. C. 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for antiosteoporotic effect of estrogen. Proc Natl Acad Sci USA 89:883-891; 1992.
16. 16. Grandien, K., Bäckdahl, M., Ljunggren, Ö., Gustafsson, J., and Berkenstam, A. Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology 136:2223-2229; 1995.
17. 17. Gray, T. K., Flynn, T. C., Gray, K.M., and Nabell, L. M. 17β-Estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci USA 84:6267-6271; 1987.
18. 18. Gray, T. K., Mohan, S., Linkhart, T. A., and Baylink, D. J. Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106. Biochem Biophys Res Commun 158:407-412; 1989.
19. 19. Gronowicz, G., Woodiel, F. N., McCarthy, M. B., and Raisz, L. G. In vitro mineralization of fetal rat parietal bones in defined serum-free medium: Effect of β-glycerol phosphate. J Bone Miner Res 4:313-324; 1989.
20. 20. Gronowicz, G., Pastizzo, G., and Ahmad, M. 17β-Estradiol affects the adhesion and migration of osteoblastic cells [abstract C214]. J Bone Miner Res 9:S384; 1994.
21. 21. Huff, K. K., Knabbe, C., Lindsey, R., Kaufman, D., Bronzert, D., Lippman, M. E., and Dickson, R. B. Multihormonal regulation of insulin-like growth factor-1-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 2:200-208; 1988.
22. 22. Kaneko, K. J., Furlow, J. D., and Gorski, J. Involvement of the coding sequence tor the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol Endocrinol 7:879-888; 1003.
23. 23. Komm, B. S., Terpening, C. M., Benz, D. J., Graeme, K. A., Gallegos, A., Korc, M., Greene, G. L., O'Malley, B. W., and Haussler, M. R. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-84; 1988.
24. 24. Korach, K. S. Insight from the study of animal lacking functional estrogen receptor. Science 266:1524-1527; 1994.
25. 25. Lindsay, R., Hart, D. M., and Clark, D. M. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759-763; 1984.
26. 26. Manolagas, S. C. and Jilka, R. L. Bone marrow, cytokines, and bone remodelling - emerging insights into the pathophysiology of osteoporosis. N Engl J Med 305-311; 1995.
27. 27. Marcus, R. The relationship of estrogen to bone health. Marcus, R., ed. Osteoporosis, London: Blackwell; 1994; 293-308.
28. 28. Masamura, S., Santner, S. J., Heitjan, D. F., and Santen, R. J. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80:2918-2925; 1995.
29. 29. Morse, B. S., Guiliani, D., Sorenmekun, M., Difino, S., and Guiliani, R. Adaptation of hematopoietic tissue resulting from estrone-induced osteosclerosis in mice. Cell Tissue Kinet 7:113-123; 1974.
30. 30. Ota, D. M., Jones, L. A., Jackson, G. L., Jackson, P. M., Kemp, K., and Bauman, D. Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients. Cancer 57:558-562; 1986.
31. 31. Oursler, M. J., Cortese, C., Keeting, P., Anderson, M. A., Bonde, S. K., Riggs, B. L., and Spelsberg, T. H. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129:3313-3320; 1991.
32. 32. Partridge, W. M., Mietus, L. F., Frumar, A.M., Davidson, B. J., and Judd, H. L. Effects of human serum on transport of testosterone and estradiol into rat brain. Am J Physiol 239:E101-E108; 1980.
33. 33. Reed, M. J., Oestrogens, Gray, C. H. and James, V. H. T., Eds. Hormones in blood, 3rd ed., Vol. 4. London: Academic; 1983:317-348.
34. 34. Reginster, J. Y., Sarlet, N., Deroisy, R., Albert, A., Gaspard, U., and Franchimont, P. Minimal levels of serum estradiol prevent postmenopausal bone loss. Calcif Tissue Int 51:340-343; 1992.
35. 35. Robey, P. G. Cell-mediated calcification in vitro. Bonucci, E., ed. Calcification in Biological Systems, London: CRC; 1993;107-127.
36. 36. SAS Institute Inc., SAS Technical Report, SAS/STAT software: Changes and enhancements, Release 6.10. Cary, NC: SAS Institute; 1995.
37. 37. Schwartz, Z., Soskolne, W. A., Goldstein, M. Adi, S., and Ornoy, A. Direct and sex-specific enhancement of bone formation and calcification by sex steroids in fetal mice long bone in vitro (biochemical and morphometric study). Endocrinology 129:1167-1174; 1991.
38. 38. Slootweg, M. C., Ederveen, A. G. H., Schot, L. P. L., Schoonen, W. G. E. J., and Kloosterboer, H. J. Oestrogen and progestogen synergistically stimulate human and rat osteoblast proliferation. J Endocrinol 133:R5-R8; 1992.
39. 39. Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., and Korach, K. S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 331:1056-1061; 1994.
40. 40. Takano-Yamamoto, T. and Rodan, G. A. Direct effects of 17β-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87:2172-2176; 1990.
41. 41. Tobias, J. H., Chow, J., Colston, K. W., and Chambers, T. J. High concentrations of 17β-estradiol stimulate trabecular bone formation in adult female rats. Endocrinology 128:408-412; 1991.
42. 42. Turner, R. T., Colvard, D. S., and Spelsberg, T. C. Estrogen inhibition of periosteal bone formation in rat long bones: Down regulation of gene expression for bone matrix proteins. Endocrinology 127:1346-1351; 1990.
43. 43. Urist, M. R., Budy, A. M., and McLean, F. C. Endosteal bone formation in estrogen-treated mice. J Bone Jt Surg 32A: 143-162; 1950.
44. 44. Wakeling, A. E., Dukes, M., and Bowler, J. A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873; 1991.